找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Critical Issues in Head and Neck Oncology; Key Concepts from th Jan B. Vermorken,Volker Budach,Brian O’Sullivan Conference proceedings‘‘‘‘‘

[復(fù)制鏈接]
樓主: burgeon
41#
發(fā)表于 2025-3-28 16:44:22 | 只看該作者
42#
發(fā)表于 2025-3-28 21:24:33 | 只看該作者
43#
發(fā)表于 2025-3-29 01:47:59 | 只看該作者
44#
發(fā)表于 2025-3-29 03:54:05 | 只看該作者
45#
發(fā)表于 2025-3-29 10:35:09 | 只看該作者
Kapitel 6: Der Nil und sein Einzugsgebieto reduce toxicity, improve adherence, and maintain adequate anti-tumour activity. Low-dose (usually 40?mg/m.) cisplatin given in weekly intervals emerged as the preferred alternative to the standard, high-dose regimen. But do we have enough evidence to support this approach and which patients might
46#
發(fā)表于 2025-3-29 11:28:26 | 只看該作者
47#
發(fā)表于 2025-3-29 18:47:22 | 只看該作者
Felix Schl?pfer,Christian Fichtertient and a tailored approach with preventative indications and therapeutic interventions represent key factors. This approach could be easily identified within a “simultaneous care” strategy, as the optimal supportive measures are provided concurrently to the best therapeutic approach since the beg
48#
發(fā)表于 2025-3-29 23:43:50 | 只看該作者
Biomarkers for Hypoxia, HPVness, and Proliferation from Imaging Perspectiveound), statistical (mainly related to selection of subset of relevant biomarkers), and translational (not enough understanding by clinicians, not easily implementable within clinical workflow). We currently foresee that the next artificial intelligence (AI)-driven technique to find its way into clin
49#
發(fā)表于 2025-3-30 01:33:11 | 只看該作者
50#
發(fā)表于 2025-3-30 05:39:50 | 只看該作者
The Role of Liquid Biopsies for Monitoring Disease Evolutionently, first studies have been initiated for studying the diagnostic value of mutant variants in plasma-derived ctDNA for treatment selection, response assessment and early detection of treatment failure..Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) represents a malignancy associated with
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-31 13:37
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
饶平县| 富顺县| 永德县| 内江市| 遵义市| 襄汾县| 荣成市| 大余县| 瓮安县| 息烽县| 张北县| 宽甸| 迁安市| 汾阳市| 壤塘县| 盐边县| 邢台县| 阿拉尔市| 福海县| 盐亭县| 寿光市| 顺义区| 仪陇县| 洪洞县| 平江县| 铜鼓县| 文水县| 台江县| 环江| 漠河县| 思茅市| 武山县| 芒康县| 嘉义市| 庐江县| 大荔县| 方正县| 潮安县| 渝中区| 金秀| 鄯善县|